Carol Giltner Gallagher Atara Biotherapeutics, Inc. (ATRA) insider trading activity

Carol Giltner Gallagher is of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 629,608 shares of ATRA, which is worth approximately $5.61 Million. The most recent transaction as insider was on Mar 31, 2024, when has been sold 150,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 630K

0% 3M change

232.39% 12M change

Total Value Held $5.61 Million

Carol Giltner Gallagher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2024	BUY Grant, award, or other acquisition	-	150,000 Added 19.24%	629,608 Common Stock
Nov 14 2023	BUY Open market or private purchase	$28,203 $0.31 p/Share	90,980 Added 16.53%	459,418 Common Stock
Nov 13 2023	BUY Open market or private purchase	$39,384 $0.22 p/Share	179,020 Added 32.7%	368,438 Common Stock
May 31 2023	BUY Grant, award, or other acquisition	-	57,000 Added 23.13%	189,418 Common Stock
Jun 23 2022	BUY Grant, award, or other acquisition	-	20,500 Added 13.41%	132,418 Common Stock
Jun 08 2021	BUY Grant, award, or other acquisition	-	11,000 Added 8.96%	111,818 Common Stock

Also insider at

TPTX

Turning Point Therapeutics, Inc.

Director

CERT

Certara, Inc. Healthcare

PMVP

PMV Pharmaceuticals, Inc. Healthcare

FLAC

Frazier Lifesciences Acquisition Corp Financial Services

Director

MRTX

Mirati Therapeutics, Inc. Healthcare

CGG